Oratech Pharmaceuticals
Develops oral drug delivery technologies, including an oral insulin program.
Company Overview
Snapshot
Founded in March 2026, Oratech Pharmaceuticals operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on advancing its oral drug delivery assets.
Business overview
Oratech Pharmaceuticals is a pharmaceutical venture dedicated to the development and commercialization of oral drug delivery assets. The company's core technology includes an oral insulin capsule program, leveraging advanced oral protein delivery technology and strategic manufacturing partnerships. Oratech Pharmaceuticals is focused on progressing clinical development and regulatory pathways for oral insulin, with plans to expand its oral delivery platform to additional therapeutics. It operates within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Drug Delivery.
Log in to access full profile ›Company Intelligence Q&A
- When was Oratech Pharmaceuticals founded?
- Oratech Pharmaceuticals was founded in March 2026.
- What is Oratech Pharmaceuticals' primary focus?
- Oratech Pharmaceuticals focuses on advancing and commercializing oral drug delivery assets, including an oral insulin capsule program, and expanding its oral delivery platform to other therapeutics.
- What is the current employee count for Oratech Pharmaceuticals?
- Oratech Pharmaceuticals currently has 1–10 employees.
- In which sector does Oratech Pharmaceuticals primarily operate?
- Oratech Pharmaceuticals primarily operates in the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology and Drug Delivery.
- What is the current product stage of Oratech Pharmaceuticals?
- Oratech Pharmaceuticals' product is currently in the Clinical Trial stage, indicating that its oral drug delivery assets, such as the oral insulin capsule program, are undergoing clinical development and regulatory pathways.